Investigating the potential of synthesized body odors to enhance a mindfulness treatment for social anxiety – a single centre, double-blind randomized controlled trial

Karolinska Institutet0 个研究点目标入组 133 人开始时间: 2023年12月18日最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•1. Aged between 18 and 35 years old
•2. Female gender
•3. A score over 30 on the Liebowitz Social Anxiety Scale in its self-report formulation (LSAS-SR)
•4. A confirmation of the disorder during a face-to-face interview (SCID 5-CV)
•5. Normosmic as screened with Sniffin’ Stick test
•6. No pregnancy
•7. Non-smokers

•1. Chronic rhinitis or other conditions that may affect the ability to perceive odors
•2. Breastfeeding
•3. Presence of other mental disorders (including substance abuse disorders) apart from major depression, chronic depression, minor depression, or dysphoria and social anxiety disorder
•4. Presence of any severe somatic or neurological conditions
•5. Use of psychotropic drugs at the moment of the recruitment (including antidepressants, antipsychotics, anxiolytics and mood stabilizers)
•6. Presently undergoing psychological therapy,
•7. Presence of severe psychotic symptoms (i.e., hallucinations and/or delusions)
•8. Presence of suicidal thoughts
•9. Incapability to understand and to give an informed consent for the experiment

发起方